Real-world adoption of FDA-approved peanut oral immunotherapy with palforzia

J Allergy Clin Immunol Pract. 2022 Apr;10(4):1120-1122.e1. doi: 10.1016/j.jaip.2021.12.022. Epub 2022 Jan 1.

¹ Division of Allergy, Immunology and Rheumatology, University of Rochester School of Medicine and Dentistry, Rochester, NY. Electronic address: [email protected].
² Division of Allergy, Immunology and Rheumatology, University of Rochester School of Medicine and Dentistry, Rochester, NY; Division of Allergy, Immunology and Rheumatology, Rochester Regional Health, Rochester, NY.
³ Division of Allergy, Immunology and Rheumatology, Rochester Regional Health, Rochester, NY.
⁴ Department of Medicine, Mercy Hospital, Springfield, Mo.
⁵ Division of Allergy, Immunology and Rheumatology, University of Rochester School of Medicine and Dentistry, Rochester, NY; Division of Allergy, Immunology and Rheumatology, Rochester Regional Health, Rochester, NY. Electronic address: [email protected].

No abstract available

MeSH terms